Ocugen, Inc.
Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function…
Biotechnology
US, Malvern [HQ]
Revenue Breakdowns
Segment Analysis Beta
The financial segments are sourced from the SEC' 10-K statement.Revenue By Top Segments
Ocugen, Inc. can't present it's sankey chart.
Historical Revenue By Segment
Last 3Y, in million USDOcugen, Inc. can't present revenue by segment
Get PRO Today
With PRO you can bypass the blur for the segment revenues of Ocugen, Inc..
If you want to see a demo, head over to the financial segments of AAPL